Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares of the company, with an aggregate market value of $95,182.98, on 08/13/2024. These shares were originally acquired on 06/14/2023 through a stock option exercise, purchased from the issuer with cash. This planned sale follows a three-month period where a total of 60,000 shares were sold by the officer, generating gross proceeds of $497,232.86. The notice of the upcoming sale was filed on the same date as the planned sale, with the sale instructions having been adopted earlier on 03/01/2024.

Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares of the company, with an aggregate market value of $95,182.98, on 08/13/2024. These shares were originally acquired on 06/14/2023 through a stock option exercise, purchased from the issuer with cash. This planned sale follows a three-month period where a total of 60,000 shares were sold by the officer, generating gross proceeds of $497,232.86. The notice of the upcoming sale was filed on the same date as the planned sale, with the sale instructions having been adopted earlier on 03/01/2024.